Click here to view the Blue Cross Blue Shield BCBS Massachusetts Medical Policy Updates »…
Capital Blue Cross Medical Policy Updates – July 2021
Click here to view the Capital Blue Cross Medical Policy Updates »
July 2021 Capital Blue Cross Medical Policy Updates:
- Actigraphy
- Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry
- Antiemetic Medical Drug Program
- Antiemetic Medical Drug Program Summary with optional step through generic
- Aqueous Shunts and Stents for Glaucoma
- ATTR Amyloidosis
- ATTR Amyloidosis
- Bendamustine Products
- Bioimpedance Devices for Detection and Management of Lymphedema
- Breyanzi (lisocabtagene maraleucel)
- Cabazitaxel (Jevtana®)
- Cabazitaxel (Jevtana®)
- Cardioverter-Defibrillators (Implantable and External)
- Chromosomal Microarray Testing for The Evaluation of Pregnancy Loss
- Cooling Devices Used in The Outpatient Setting
- Coverage with Evidence Development
- Cranial Electrotherapy Stimulation (Ces) And Auricular Electrostimulation
- Denosumab – Oncology
- Denosumab – Osteoporosis
- Denosumab – Osteoporosis
- Dermatologic Applications of Photodynamic Therapy
- Diagnosis And Treatment of Dry Eye Syndrome
- Drug Infusion Site of Service
- Endovascular Grafts for Abdominal Aortic Aneurysms
- Esophageal Ph Monitoring
- Evenity (romosozumab-aqqg)
- Evenity (romosozumab-aqqg)
- Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
- Experimental And Investigational Procedures
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
- Genetic And Protein Biomarkers for The Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Hereditary Angioedema
- Hereditary Angioedema
- Injectable and Health Care Administered Oncology
- Injectable and Health Care Administered Oncology
- Injectable and Health Care Administered Oncology
- Interleukin-5 (IL-5) Inhibitors
- Interleukin-5 (IL-5) Inhibitors
- Interleukin-5 (IL-5) Inhibitors
- Interventions For Progressive Scoliosis
- Laboratory And Genetic Testing for Use Of 5-Fluorouracil in Patients with Cancer
- Methadone Treatment for Opiate Addiction
- Negative Pressure Wound Therapy in The Outpatient Setting
- Ocular Angiogenesis Inhibitors
- Optical Diagnostic Devices for Evaluation of Skin Lesions Suspected of Malignancy
- Oxlumo (lumasiran)
- Percutaneous Left-Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation
- Power Wheelchairs, Power Operated Vehicles (Povs) and Related Accessories
- Preimplantation Genetic Testing
- Therapeutic Radiopharmaceuticals in Oncology
- Treatments Of the Prostate
- Wireless Capsule Endoscopy to Diagnose Disorders of The Small Bowel, Esophagus, and Colon
- Wound & Burn Care & Specialized Treatment Centers
- Xolair (omalizumab)
Click here to view the Capital Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.